25021-0455 Octreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

25021-0455

Brand Name:

Octreotide Acetate

Generic Name:

Octreotide Acetate

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: Octreotide Acetate

Strength: 1000.0

Unit: ug/mL

Packages:

Code: 25021-0455-05

Description: 1 VIAL in 1 CARTON (25021-455-05) / 5 mL in 1 VIAL

Effective Date: Dec. 15, 2013

Discontinued: Feb. 29, 2020

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Yes

Status:

In Use